ACA
Overvalued by 3.5% based on the discounted cash flow analysis.
Market cap | $4.22 Billion |
---|---|
Enterprise Value | $4.65 Billion |
Dividend Yield | $0.1998 (0.23%) |
Earnings per Share | $2.93 |
Beta | 1.18 |
Outstanding Shares | 48,600,000 |
Avg 30 Day Volume | 271,270 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 29.55 |
---|---|
PEG | -99.99 |
Price to Sales | 1.8 |
Price to Book Ratio | 1.8 |
Enterprise Value to Revenue | 1.97 |
Enterprise Value to EBIT | 25.96 |
Enterprise Value to Net Income | 32 |
Total Debt to Enterprise | 0.13 |
Debt to Equity | 0.26 |
No data
No data